--- title: "Pharmaceutical Stocks To Keep An Eye On - September 6th" type: "News" locale: "en" url: "https://longbridge.com/en/news/298138572.md" description: "MarketBeat's stock screener identifies seven pharmaceutical stocks to watch on September 6th: Eli Lilly, AbbVie, Johnson & Johnson, Gilead Sciences, McKesson, Abbott Laboratories, and Pfizer. These companies were selected based on having the highest dollar trading volume among pharmaceutical stocks in recent days." datetime: "2026-09-06T18:01:47.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298138572.md) - [en](https://longbridge.com/en/news/298138572.md) - [zh-HK](https://longbridge.com/zh-HK/news/298138572.md) generator: "portal-rs" --- # Pharmaceutical Stocks To Keep An Eye On - September 6th - Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It Eli Lilly and Company, AbbVie, Johnson & Johnson, Gilead Sciences, McKesson, Abbott Laboratories, and Pfizer are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies involved in researching, developing, manufacturing, or selling medicines and other drug-related products. For stock market investors, these stocks may offer growth potential from successful treatments and strong sales, but they can also carry risks related to clinical trials, regulatory approval, competition, and patent expiration. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days. Get **Eli Lilly and Company** alerts: ## Eli Lilly and Company (LLY) Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. - MarketBeat Week in Review – 08/31 - 09/04 Read Our Latest Research Report on LLY ## AbbVie (ABBV) AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. - Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity Read Our Latest Research Report on ABBV ## Johnson & Johnson (JNJ) Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. Read Our Latest Research Report on JNJ ## Gilead Sciences (GILD) Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. Read Our Latest Research Report on GILD ## McKesson (MCK) McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. Read Our Latest Research Report on MCK ## Abbott Laboratories (ABT) Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. Read Our Latest Research Report on ABT ## Pfizer (PFE) Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. Read Our Latest Research Report on PFE ## Read More - MarketBeat's Top Five Stocks to Own in September 2026 - AI Token Costs Are Changing the Hardware vs. Software Debate - 3 ETFs That Could Move as Rate Expectations Shift - 3 Stocks With September Catalysts Investors Shouldn’t Ignore - Ollie's Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains - Why Hewlett Packard Enterprise’s Sell-Off May Not Last *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Eli Lilly and Company Right Now? Before you consider Eli Lilly and Company, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list. While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [LLY.US](https://longbridge.com/en/quote/LLY.US.md) - [ABT.US](https://longbridge.com/en/quote/ABT.US.md) - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) - [MCK.US](https://longbridge.com/en/quote/MCK.US.md) - [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md) - [GILD.US](https://longbridge.com/en/quote/GILD.US.md) - [PFE.US](https://longbridge.com/en/quote/PFE.US.md) - [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md) - [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md) - [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md) - [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md) - [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md) - [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md) ## Related News & Research - [Eli Lilly and Company $LLY Shares Purchased by Integrated Wealth Concepts LLC](https://longbridge.com/en/news/298698438.md) - [How Concerned Should Income Investors Be About Pfizer's Dividend?](https://longbridge.com/en/news/298813592.md) - [AbbVie chips in for neurology advocacy through PGA Tour campaign](https://longbridge.com/en/news/299059575.md) - [Eli Lilly and QurCan sign genetic medicine deal](https://longbridge.com/en/news/299162046.md) - [Johnson & Johnson (JNJ) Posts PAPILLON Survival Data, Is The Stock Fully Priced?](https://longbridge.com/en/news/298918543.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**